Understanding your biopsy result

What Causes a False Negative — Biopsy?

A biopsy that comes back normal can be wrong. When cancer is present but the sample misses it, the result is a false negative — and understanding why this happens can help you ask the right questions.

Medically reviewed by Dr. C. Raghavendra Reddy, Medical Oncologist, MBBS (Gold Medal) · DNB · DM (Medical Oncology, Gold Medal) · Last reviewed September 2026

Sampling error is the leading cause — The needle can pass through tissue beside the abnormal area rather than through it.
Small lesions are harder to target — The smaller the lesion, the narrower the margin for error when positioning the needle.
Image guidance significantly reduces the risk — Ultrasound, CT or MRI-guided biopsies direct the needle to the target in real time.
A negative result is not always the final word — Your doctor weighs the biopsy against your scan findings and symptoms before reaching a conclusion.

Book Free Consultation 1800 202 8726

4.8 · 800+ Google reviews · 15,000+ patients treated

17+

Cancer Specialists
on Panel

96.9%

Breast Cancer
Survival Rate*

15,000+

Patients
Treated

4.8★

Google Rating
(800+ reviews)

A false negative biopsy most often happens because the needle sampled tissue beside the abnormal area rather than from within it. This is called sampling error. Small lesions, deep or awkwardly placed tumours, and tumours where abnormal cells are unevenly distributed all raise the risk.

Why does a biopsy miss cancer that is actually there?

The most common reason is sampling error: the needle passes through normal tissue sitting just beside the abnormal area, not through it. The result comes back as benign because the cells that were collected are benign — the abnormal cells were never reached.

This is not a failure of the laboratory. The tissue that reaches the pathologist is analysed correctly. The problem happens at the moment the sample is taken, before any laboratory work begins.

Tumour heterogeneity adds a separate difficulty. Different parts of the same tumour can look different under the microscope. A needle that lands in the right lesion but samples the wrong section may still collect cells that appear normal.

Does the size or position of the lesion affect the result?

Yes — both matter. Smaller lesions are harder to target precisely, and the margin for error is narrow. ESMO guidance notes that for small lesions, a negative core biopsy does not reliably exclude malignancy.

Position adds to the difficulty. A lesion behind a rib, close to a major blood vessel, or at an angle that limits direct needle access means fewer passes can safely be made. Fewer passes reduce the chance of sampling the abnormal area.

What reduces the chance of a false negative biopsy?

Image guidance — ultrasound, CT or MRI — directs the needle to the target in real time rather than by feel alone.
Taking multiple cores from different parts of the lesion increases the chance of capturing abnormal cells.
A specialist with experience in that body region improves needle placement and targeting accuracy.
A second pathology review of your slides by a specialist in the relevant cancer type catches laboratory reading errors.
Comparing the biopsy result with your scan findings — if they do not match, further sampling is considered.

Meet the Specialists

17+ senior cancer specialists. One panel for your case.

Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.

Medical Oncologist

Dr. Naresh Gundu

MBBS, DNB (Internal Medicine), DM (Medical Oncology)

View Profile

Medical Oncologist

Dr. C. Raghavendra Reddy

MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)

View Profile

Medical Oncologist

Dr. Bharati Devi Gorantla

MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)

View Profile

Medical Oncologist

Dr. Owais Mohammed

MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)

View Profile

Medical Oncologist

Dr. T. Raghavender Reddy

MBBS, DM (Medical Oncology), MD (Radiation Oncology)

View Profile

Medical Oncologist

Dr. N. Kiranmayee

MBBS, DM (Medical Oncology), MD (Internal Medicine)

View Profile

Surgical Oncologist

Dr. Muralidhar Muddusetty

MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)

View Profile

Surgical Oncologist

Dr. Raghavendra Naik

MBBS, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Mohammed Imaduddin

M.B.B.S, MS (General Surgery), M.Ch (Surgical Oncology)

View Profile

Surgical Oncologist

Dr. Vinay Mamidala

MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)

View Profile

Surgical Oncologist

Dr. Paila Gowri Naidu

MBBS, MS (General Surgery), M.Ch (Surgical Oncology), FMAS

View Profile

Radiation Oncologist

Dr. Venkata Sushma P

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Kirti Ranjan Mohanty

MBBS, MD (Radiation Oncology)

View Profile

Radiation Oncologist

Dr. Gangadhar Vajrala

MBBS, MD (Radiation Oncology), MPH

View Profile

Hematologist

Dr. Basudev Pokhrel

MBBS, M.D (Immunohematology & Blood Transfusion)

View Profile

Interventional Radiologist

Dr. Mohammed Imran

View Profile

Surgical Oncologist

Dr. Vajja Sandeep Kumar

MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology

View Profile

Surgical Oncologist

Dr. Sridhar Kamani

MBBS, MS (General Surgery), DrNB (Surgical Oncology)

View Profile

Want a specific doctor for your case? Mention them when booking.

Book Free Consultation

Get a straight answer from a specialist

45 minutes, your reports reviewed, your questions answered in plain language.

Book Free Consultation Call 1800 202 8726

What do the terms in your biopsy report mean?

Sampling error: The needle collected tissue from beside the abnormal area rather than from within it. The laboratory result reflects what was sampled, not necessarily what the whole lesion contains.
Tumour heterogeneity: Different parts of the same tumour can look different under the microscope. A sample from one section may appear benign even when other sections carry cancer cells.
Core needle biopsy: A hollow needle removes a thin cylinder of tissue for analysis. Several cores are typically taken from different parts of the lesion to improve the chance of sampling the right area.
Image-guided biopsy: The needle is steered in real time using ultrasound, CT or MRI imaging. This improves accuracy compared to palpation-guided sampling for most deep or small lesions.

What should you do if your result is negative but something still worries you?

A biopsy result is one piece of evidence. Your doctor considers it alongside your scan findings, your clinical history, and your symptoms — not in isolation.

If the imaging and clinical picture do not fit a benign result, your team may recommend a repeat biopsy, a different biopsy technique, or sampling from a different site.

Tell your treating doctor directly if you are not reassured. That conversation belongs in clinic, not left unspoken. It is part of how a result that does not fit the full picture gets resolved.

Common questions families ask after a negative biopsy result

How common is a false negative on biopsy?

There is no single figure that applies across all cancer types and biopsy methods. Rates vary considerably depending on the organ, the size of the lesion, the technique used, and how the laboratory is equipped. What ESMO and NCCN guidance consistently emphasises is that a negative result in the presence of suspicious imaging findings should prompt further evaluation rather than discharge. Ask your team what the false negative rate is for the specific biopsy method used for your situation — that is the number that matters, not a population average.

Can a second biopsy give a different result?

Yes. A repeat biopsy can target a different part of the lesion, use a different approach, or be guided by a different imaging modality. Whether one is recommended depends on whether the first result fits the clinical picture. If your scan findings and symptoms suggest malignancy and the biopsy does not match that picture, your team will likely discuss a repeat biopsy without you having to press for it. If they do not, it is entirely reasonable to raise the question yourself.

Is a surgical biopsy more accurate than a needle biopsy?

A surgical or excision biopsy removes a larger section of tissue and generally has a lower false negative rate than a needle biopsy, but it carries a higher procedural risk and is not always appropriate depending on where the lesion sits and your general health. For many lesions, an image-guided needle biopsy is safe, sufficiently accurate, and is the appropriate first step. Your team will recommend the approach most likely to give a reliable result with the least risk for your specific situation.

What happens if the scan still looks suspicious after a negative biopsy?

Your team will weigh the biopsy result against your scan findings, your symptoms, and any change in the lesion over time. A result that does not fit a suspicious imaging appearance is not automatically accepted as the final answer. Options include a repeat biopsy from a different part of the lesion, close monitoring with repeat imaging, or a multidisciplinary review where radiology and pathology look at the case together. The degree of concern raised by the imaging drives how quickly the next step is taken.

Could the laboratory have misread the slides?

Laboratory reading errors are less common than sampling errors but do occur. Pathology interpretation involves professional judgement, and a borderline result may be read differently by two experienced pathologists. A second opinion from a specialist pathologist — particularly one focused on that cancer type — is a routine and reasonable request in oncology. Ask your treating doctor to arrange this if you have concerns. It is standard clinical practice, not an accusation.

Explore 112 more Markers, Molecular Testing and Test Accuracy topics

False Negatives & Accuracy

Breast Markers: ER, PR, HER2, Ki-67

IHC Markers Explained

Inadequate, Inconclusive & Repeat Biopsy

Labs, Slides, Blocks & Second Opinions

Molecular & Genomic Testing

All Markers, Molecular Testing and Test Accuracy →

Next step

Still not sure what applies to you?

Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.

Book Free Consultation Call 1800 202 8726

Common questions

Frequently asked questions

How often do biopsies give a false negative result?

False negative rates vary widely depending on the organ, lesion size, biopsy technique and laboratory, and there is no single figure that covers all situations. What ESMO and NCCN guidance consistently states is that a negative biopsy in the presence of suspicious imaging findings should prompt further evaluation, not reassurance alone. Ask your team what the false negative rate is for the specific biopsy method used for you — that is the figure that matters.

Can I ask for a second biopsy if I am not reassured by the result?

Yes, and it is a reasonable request. A repeat biopsy can target a different part of the lesion, use a different technique, or approach from a different angle. Whether it is recommended depends on how closely the first result matches your scan findings and symptoms. If they do not match, your team will likely raise it themselves. Bring your concern directly to your treating doctor — that conversation is how a mismatched result gets resolved.

Is one type of biopsy more accurate than another?

A surgical biopsy removes more tissue and generally has a lower false negative rate than a needle biopsy, but carries higher procedural risk and is not always appropriate. Among needle techniques, image-guided approaches using ultrasound, CT or MRI in real time are more accurate than palpation-guided biopsies for most deep lesions. Taking multiple cores from different areas of the lesion also improves accuracy. Your team will recommend the approach most likely to give a reliable result with the least risk for your situation.

What does my doctor do when the scan looks suspicious but the biopsy is negative?

Your doctor compares the biopsy result against your scan findings, your clinical history and your symptoms as a whole. A negative result that does not fit a suspicious imaging appearance is not automatically taken as the final answer. Your team may recommend a repeat biopsy, close monitoring with repeat imaging, or a multidisciplinary review involving radiology and pathology together. The degree of concern the imaging raises drives how quickly the next step is taken.

Could the pathologist have misread my biopsy slides?

Laboratory reading errors are less common than sampling errors but do occur. Pathology interpretation involves professional judgement, and borderline results can be read differently by different pathologists. A second opinion from a specialist pathologist — particularly one focused on your cancer type — is a routine request in oncology. Ask your treating doctor to arrange this if you have concerns. It is standard clinical practice and does not require a formal complaint.

Can CION arrange a second pathology opinion on my biopsy?

Yes. If you are concerned about how your slides were interpreted, a second pathology review can be arranged through your CION oncologist. This is a routine request in oncology settings and is particularly useful when a specialist in your cancer type wants their own laboratory's interpretation. Bring your original biopsy report, and ask your first hospital whether they can transfer the tissue blocks — your CION team can advise you on the process.

Full index